EUVIMEDEUVIMED entdecken
Crossref

The natural clinical course of endoscopic transpapillary gallbladder drainage (ETGBD) for benign acute cholecystitis

T. H. Lee, G. H. Choi, J. K. Yang, Y. N. Lee, I. S. Shin, J. H. Moon, Y. D. Cho, N. H. Heo, S. H. Park

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S275

DOI: 10.1055/s-0044-1783342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von T. H. Lee und 8 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Endoscopic transpapillary gallbladder drainage (ETGBD) in patients with symptomatic gallbladder (GB) diseases is a safe and feasible bridge therapy for patients at high risk of surgery or with terminal liver disease awaiting transplantation. However, there are few reports considering the long-term outcomes in natural clinical courses in benign symptomatic GB diseases. The presented study investigated the long-term natural clinical outcomes of ETGBD in patients with acute cholecystitis at high risk of surgery or who refused to undergo cholecystectomy.

Methods

Twenty-six consecutive patients with acute cholecystitis were enrolled from March 2007 to December 2011, excluding malignancy-related cholecystitis, and were followed up to September 2023. Endoscopic transpapillary GB stenting (ETGS) using a 7 Fr double pigtail stent (length, 7 to 15 cm) or endoscopic naso-GB drainage (ENGBD) using a 5 Fr nasobiliary tube was performed. Clinical outcomes, adverse events, and event-free follow-up duration were observed whenever symptoms developed through ambulatory follow-up monitoring or phone consultations. [ 1 ] [ 2 ]

Results

ETGBD was successful in 26 (81.3%) of the 32 candidates. The indications were refusal of operation in 13 (50%) patients, high risk for an operation in 2 (8%) patients, and both categories in 11 (42%) patients. The average procedure time from intubation of the duodenum to completion of GB drainage was 19.3 (6.7) minutes in ETGS and 13.6 (5.9) minutes in ENGBD, respectively. During the follow-up period (median 3564 days, range 494-6,074 days), nine patients were lost to follow-up at least one year later. Late adverse events requiring ERCP developed in 8/18 (44.4%) patients in the ETGS group and 3/8 (37.5%) in the ENGBD group. The most common cause of adverse events was biliary stones (6/18) in the ETGS group and cholecystitis (2/8) in the ENGBD group, respectively. Distal migrated or complicated stents were all removed and then followed up. A protocol-based median complication-free duration was 4,664 days (range 30–6,074 days), as calculated by the Kaplan-Meier method; 4,664 days (302–6,074 days) in ETGS and 3,029 days (30–4,375 days) in ENGBD, respectively (p-value=0.997).

Conclusions

Primary ETGBD in benign acute cholecystitis is technically feasible and effective for a long time in patients at high risk for surgery or who refuse the operation. ETGS tended to provide a longer event-free duration than ENGBD without statistical difference. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Lee, T. H., Choi, G. H., Yang, J. K., Lee, Y. N., Shin, I. S., Moon, J. H., Cho, Y. D., Heo, N. H., & Park, S. H. (2024). The natural clinical course of endoscopic transpapillary gallbladder drainage (ETGBD) for benign acute cholecystitis. Endoscopy, 56(S 02 S 02), S275. https://doi.org/10.1055/s-0044-1783342

Vancouver

Lee TH, Choi GH, Yang JK, Lee YN, Shin IS, Moon JH, et al. The natural clinical course of endoscopic transpapillary gallbladder drainage (ETGBD) for benign acute cholecystitis. Endoscopy. 2024;56(S 02 S 02):S275. doi:10.1055/s-0044-1783342

BibTeX
@article{Lee2024,
  author = {Lee, T. H. and Choi, G. H. and Yang, J. K. and Lee, Y. N. and Shin, I. S. and Moon, J. H. and Cho, Y. D. and Heo, N. H. and Park, S. H.},
  title = {The natural clinical course of endoscopic transpapillary gallbladder drainage (ETGBD) for benign acute cholecystitis},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S275},
  doi = {10.1055/s-0044-1783342}
}
Kostenlos starten →